Trial Profile

Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Pneumococcal Vaccine 1024850A When Administered to Children Between 8 Weeks and 2 Years of Age

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix); Poliovirus vaccine live oral
Indications Pneumococcal infections; Pneumonia; Streptococcal infections
Focus Adverse reactions; Pharmacodynamics; Registrational
Sponsors GlaxoSmithKline; GSK

Most Recent Events

01 May 2017 Results published in the Pediatric Infectious Disease Journal
27 Dec 2016 Results published in the Pediatric Infectious Disease Journal
20 Jun 2013 Actual initiation date changed from Mar 2011 to Jun 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com